Lucio Annunziato
Directeur/Membre du Conseil chez ARTERRA BIOSCIENCE S.P.A.
Profil
Lucio Annunziato is an Independent Director at Arterra Bioscience SpA, and a Member of both the American Society for Pharmacology & Experimental Therapeutic and the British Pharmacological Society.
He was a Member of the Academic Governing Board at Università degli Studi di Napoli Federico II from 2011 to 2014, and served as President of the Società Italiana Di Neuroscienze from 2010 to 2012.
Postes actifs de Lucio Annunziato
| Sociétés | Poste | Début |
|---|---|---|
| ARTERRA BIOSCIENCE S.P.A. | Directeur/Membre du Conseil | - |
| American Society for Pharmacology & Experimental Therapeutic | Corporate Officer/Principal | - |
British Pharmacological Society
 British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Corporate Officer/Principal | - |
Anciens postes connus de Lucio Annunziato
| Sociétés | Poste | Fin |
|---|---|---|
| Università degli Studi di Napoli Federico II | Corporate Officer/Principal | 01/01/2014 |
| Società Italiana Di Neuroscienze | President | 01/01/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARTERRA BIOSCIENCE S.P.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| American Society for Pharmacology & Experimental Therapeutic | |
British Pharmacological Society
British Pharmacological Society Investment Trusts/Mutual FundsMiscellaneous The British Pharmacological Society is a charity and membership organization that aims to promote and advance the field of pharmacology. The private company is based in London, UK. The British company leads the way in researching and applying pharmacology worldwide. The company was founded in 1931. Rachel Lambert-Forsyth has been the CEO of the company since 2020. | Miscellaneous |
| Società Italiana Di Neuroscienze |
